Artritis psori?sica

Moll, 1973, Psoriatic arthritis, Semin Arthritis Rheumatism, 3, 55, 10.1016/0049-0172(73)90035-8 Salvarani, 1998, Psoriatic arthritis, Curr Opin Rheumatol, 10, 299, 10.1097/00002281-199807000-00004 Shbeeb, 2000, The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982-1991, J Rheumatol, 27, 1247 Woodrow, 1985, HLA antigens in psoriasis and psoriatic arthritis?, J Med Genet, 22, 492, 10.1136/jmg.22.6.492 Allen, 2001, Corneodesmosin gene expression in psoriasis vulgaris differs from normal skin and other inflammatory disorder, Lab Invest, 81, 969, 10.1038/labinvest.3780309 Gonz?lez, 2000, The OTF3 gene polymorphism confers susceptibility to psoriasis independent of the association of HLACw* 0602, J Invest Dermatol, 115, 824, 10.1046/j.1523-1747.2000.00133.x L?pez-Larrea, 1990, HLA antigens in psoriatic arthritis subtypes of a Spanish population, Ann Rheum Dis, 49, 318, 10.1136/ard.49.5.318 Gonz?lez, 1999, The MIC-A9 triplet repeat polymorphism in the transmembrane region confers additional susceptibility to develop psoriatic arthritis, and is independent of the association of Cw*0602 in psoriasis, Arthritis Rheum, 42, 1010, 10.1002/1529-0131(199905)42:5<1010::AID-ANR21>3.0.CO;2-H Mart?nez-Borra, 2003, Psorisis vulgaris and psoriatic arthritis share a 100 kb susceptibility region telomeric to HLA-C, Rheumatology, 42, 89 Rahman, 2003, CARD15: a pleiotropic autoimmune gene that confers susceptibility to psoriatic arthritis, Am J Hum Genet, 73, 677, 10.1086/378076 Njobvu, 1998, Spondyloarthropaty and HIV infection in Gambia, J Rheumatol, 25, 1553 Taglione, 1999, Hepatitis C virus infection: prevalence in psoriasis and psoriatic arthritis, J Rheumatol, 26, 370 Eedy, 1991, Neuropeptides in psoriasis: an immunocytochemical and radioimmunoassay study, J Invest Dermatol, 96, 434, 10.1111/1523-1747.ep12469898 Fraser, 2001, Matrix metalloproteinase 9, apoptosis, and vascular morphology in early artritis, Artritis Rheum, 44, 2024, 10.1002/1529-0131(200109)44:9<2024::AID-ART351>3.0.CO;2-K Cohen, 1999, Baseline relationships between psoriasis and psoriatic arthritis: analysis of 221 patients with active psoriatic arthritis, J Rheumatol, 26, 1752 Gladman, 1987, Psoriatic arthritis. An analysis of 220 patients, Q J Med, 62, 127 McGonagle, 1998, classification of inflammatory arthritis by enthesitis, Lancet, 352, 1137, 10.1016/S0140-6736(97)12004-9 Torre Alonso, 1991, Psoriatic arthritis (PA): a clinical, immunological and radiological study of 180 patients, Br J Rheumatol, 30, 245, 10.1093/rheumatology/30.4.245 Olivieri, 1997, Toe dactylitis in patients with spondyloarthropathy: assessment by magnetic resonance imaging, J Rheumatol, 24, 926 Lambert, 1977, Psoriatic spondylitis: A clinical and radiological description of the spine in psoriatic artritis, Q J Med, 46, 411 Oliv?, 1995, El s?ndrome de SAPHO y otras espondiloartropat?as mal definidas, Rev Esp Reumatol, 22, 212 Goupille, 1996, Incidence of osteoperiostitis of the great toe in psoriatic arthritis, J Rheumatol, 23, 1553 Schatteman, 1995, Gut inflamation in psoriatic arthritis; a prospective ileocolonoscopic study, J Rheumatol, 22, 680 Kane, 2003, A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience, Rheumatology, 42I 12, 1460, 10.1093/rheumatology/keg384 Gorter, 2002, Psoriatic arthritis: Performance of rheumatologists in daily practice, Ann Rheum Dis, 61, 219, 10.1136/ard.61.3.219 Gladman, 1999, Progression in psoriatic arthritis: role of time varying clinica indicators, J Rheumatol, 26I 11, 2409 Queiro Silva, 2003, A polyarticular onset predicts erosive and deforming disease in psoriatic artritis, Ann Rheum Dis, 62, 68, 10.1136/ard.62.1.68 Kane, 2003, A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience, Rheumatology, 42I 12, 1460, 10.1093/rheumatology/keg384 Gladman, 2001, Remission in psoriatic arthritis, J Rheumatol, 28I 5, 1045 Gladman, 1998, HLA markers and progression in psoriatic arthritis, J Rheumatol, 25I 4, 730 Gupta, 1995, Sulfasalazine therapy for psoriatic arthritis: a double blind, placebo controlled trial, J Rheumatol, 22, 894 Clegg, 1996, Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study, Arthritis Rheum, 39, 2013, 10.1002/art.1780391210 Black, 1964, Methotrexate therapy in psoriatic arhritis; double-blin study on 21 patients, Jama, 189, 743, 10.1001/jama.1964.03070100037007 Willkens, 1984, Randomized, double-blind, placebo controlled trial of low-dose pulse methotrexate in psoriatic arthritis, Arthritis Rheum, 27, 376, 10.1002/art.1780270403 Abu-Shakra, 1995, Longterm methotrexate therapy in psoriatic arthritis: clinical and radiological outcome, J Rheumatol, 22, 241 Spadaro, 1995, Comparison of cyclosporin A and methotrexate in the treatment of psoriatic arthritis: a one-year prospective study, Clin Exp Rheumatol, 13, 589 Salvarani, 2001, A comparison of cyclosporine, sulfasalazine, and symptomatic therapy in the treatment of psoriatic arthritis, J Rheumatol, 28I 10, 2274 Mease, 2003, Leflunomide in the treatment of psoriatic arthritis and psoriasis: joint and skin efficay and safety in the TOPAS study [abstract], Arthritis Rheum, S342 Jones, 2003, Interventions for treating psoriatic arthritis (Cochrane Review) Mease, 2000, Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial, Lancet, 356, 385, 10.1016/S0140-6736(00)02530-7 Van den Bosch, 2002, Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (Remicade) versus placebo in active spondyloarthropathy, Arthritis Rheum, 46, 755, 10.1002/art.511 Cauza, 2002, Treatment of psoriatic arthritis and psoriasis vulgaris with the tumor necrosis factor inhibitor Remicade, Rheumatol Int, 22, 227, 10.1007/s00296-002-0246-3 Casado Burgos, 2004, Estudio multic?ntrico de tratamiento combinado con infliximab y metotrexato en pacientes con poliartritis psori?sica refractaria a metotrexato (Estudio MIPRA), Rev Esp Reumatol, 30, 187 Antoni, 2002, Open-label study of Remicade treatment for psoriatic artritis: clinical and magnetic resonance imaging measurements of reduction of inflammation, Arthritis Rheum, 47, 506, 10.1002/art.10671 Ca?ete, 2004, Antiangiogenic efects of anti-TNF therapy with infliximab in psoriaic arthritis, Arthritis Rheumatism, 50, 1636, 10.1002/art.20181